Chimeric receptors to FLT3 and methods of use thereof
MYPI2025001539A0Undetermined Publication Date: 2017-10-01AMGEN INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025001539
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2016-04-01
- Filing Date
- 2017-03-31
- Publication Date
- 2017-10-01
Abstract
Antigen binding molecules, chimeric receptors, and engineered immune cells to FLT3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and / or detection using the FLT3 antigen binding molecules and engineered immune cells. No suitable figure
Need to check novelty before this filing date? Find Prior Art
